Bayer said on Friday it was again petitioning the U.S. Supreme Court to sharply limit legal claims that its Roundup herbicide causes cancer, seeking to avoid potentially billions of dollars in damages.
Bayer renews bid for US Supreme Court to curb glyphosate cases
Bayer tells US it could halt Roundup weedkiller sales over legal risks
Bayer has told U.S. lawmakers it could stop selling Roundup weedkiller unless they can strengthen legal protection against product liability litigation.
Bayer projects improvement in 2026 after profit decline this year
Bayer on Wednesday raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a four-month high as its CEO somewhat allayed investor impatience with his turnaround efforts.
Bayer shareholders call on CEO to stem the tide of bad news
Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug development, to restore confidence and revive the company's share price that hit 20-year lows after its shock warning this week.
Bayer’s shares sink to 20-year low on 2025 earnings fall forecast
Bayer said on Tuesday that weak agricultural markets mean its earnings are likely to fall further next year, sparking a sharp fall in the German company's shares and piling pressure on its CEO to deliver on his turnaround efforts.
Cyber-Savvy Farmer
